Audentes Therapeutics, Inc. Defined Contribution Plan, Cost
Audentes Therapeutics, Inc. reported Defined Contribution Plan, Cost of $1.20 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2019-03-01
- Audentes Therapeutics, Inc. defined contribution plan, cost for the quarter ending 2018-12-31 was $200.00K.
- Audentes Therapeutics, Inc. defined contribution plan, cost for the quarter ending 2018-09-30 was $200.00K.
- Audentes Therapeutics, Inc. defined contribution plan, cost for the quarter ending 2018-06-30 was $300.00K.
- Audentes Therapeutics, Inc. defined contribution plan, cost for the quarter ending 2018-03-31 was $600.00K.
- Audentes Therapeutics, Inc. defined contribution plan, cost for fiscal 2018 was $1.20M.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|
| 2018-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $400.00K derived: sum of 2 quarters · filed 2019-03-01 | $700.00K derived: sum of 3 quarters · filed 2019-03-01 | $1.20M 10-K · filed 2019-03-01 |
| 2018-09-30 | $200.00K 10-Q · filed 2018-11-07 | $500.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.00M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $300.00K 10-Q · filed 2018-08-07 | $800.00K 10-Q · filed 2018-08-07 | ||
| 2018-03-31 | $600.00K 10-Q · filed 2018-05-10 | |||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-07 | $0.00 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 |